DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators
- PMID: 2819825
- PMCID: PMC306134
- DOI: 10.1093/nar/15.16.6713
DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators
Abstract
The DNA unwinding effects of some 9-aminoacridine derivatives were compared under reaction conditions that could be used to study drug-induced topoisomerase II inhibition. An assay was designed to determine drug-induced DNA unwinding by using L1210 topoisomerase I. 9-aminoacridines could be ranked by decreasing unwinding potency: compound C greater than or equal to 9-aminoacridine greater than o-AMSA greater than or equal to compound A greater than compound B greater than m-AMSA. Ethidium bromide was more potent than any of the 9-aminoacridines. This assay is a fast and simple method to compare DNA unwinding effects of intercalators. It led to the definition of a drug intrinsic unwinding constant (k). An additional finding was that all 9-aminoacridines and ethidium bromide inhibited L1210 topoisomerase I. Enzyme inhibition was detectable at low enzyme concentrations (less than or equal to 1 unit) and when the kinetics of topoisomerase I-mediated DNA relaxation was studied. Topoisomerase I inhibition was not associated with DNA swivelling or cleavage.
Similar articles
-
Role of DNA intercalation in the inhibition of purified mouse leukemia (L1210) DNA topoisomerase II by 9-aminoacridines.Biochem Pharmacol. 1987 Oct 15;36(20):3477-86. doi: 10.1016/0006-2952(87)90329-7. Biochem Pharmacol. 1987. PMID: 2823823
-
Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage.Biochemistry. 1985 Nov 5;24(23):6410-6. doi: 10.1021/bi00344a015. Biochemistry. 1985. PMID: 3002440
-
Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.Cancer Res. 1988 Feb 15;48(4):860-5. Cancer Res. 1988. PMID: 2827887
-
DNA topoisomerase II as a target of antineoplastic drug therapy.Cancer Metastasis Rev. 1985;4(4):263-76. doi: 10.1007/BF00048092. Cancer Metastasis Rev. 1985. PMID: 3000574 Review.
-
A role of the 9-aminoacridines and their conjugates in a life science.Curr Protein Pept Sci. 2007 Oct;8(5):471-83. doi: 10.2174/138920307782411400. Curr Protein Pept Sci. 2007. PMID: 17979762 Review.
Cited by
-
Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.J Med Chem. 2018 Nov 21;61(22):9908-9930. doi: 10.1021/acs.jmedchem.8b00639. Epub 2018 Oct 31. J Med Chem. 2018. PMID: 30336023 Free PMC article.
-
Cancer therapies utilizing the camptothecins: a review of the in vivo literature.Mol Pharm. 2010 Apr 5;7(2):307-49. doi: 10.1021/mp900243b. Mol Pharm. 2010. PMID: 20108971 Free PMC article. Review.
-
Uncharacterized Bacterial Structures Revealed by Electron Cryotomography.J Bacteriol. 2017 Aug 8;199(17):e00100-17. doi: 10.1128/JB.00100-17. Print 2017 Sep 1. J Bacteriol. 2017. PMID: 28607161 Free PMC article.
-
Synthesis and biological evaluation of 6-substituted indolizinoquinolinediones as catalytic DNA topoisomerase I inhibitors.Eur J Med Chem. 2015 Aug 28;101:525-33. doi: 10.1016/j.ejmech.2015.07.007. Epub 2015 Jul 8. Eur J Med Chem. 2015. PMID: 26188908 Free PMC article.
-
Cooperative binding of m-AMSA to nucleic acids.Nucleic Acids Res. 1988 Oct 25;16(20):9707-19. doi: 10.1093/nar/16.20.9707. Nucleic Acids Res. 1988. PMID: 3186443 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
